You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

AMINOCAPROIC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Aminocaproic patents expire, and what generic alternatives are available?

Aminocaproic is a drug marketed by Hikma, Abraxis Pharm, Baxter Hlthcare, Hospira, Luitpold, Amneal, Annora Pharma, Aurobindo Pharma, Belcher, Carnegie, Epic Pharma Llc, Florida, Sunny, Taro, Tulex Pharms Inc, Vistapharm Llc, Ani Pharms, Edenbridge Pharms, MSN, and Optimus. and is included in twenty-four NDAs.

The generic ingredient in AMINOCAPROIC is aminocaproic acid. There are six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the aminocaproic acid profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Aminocaproic

A generic version of AMINOCAPROIC was approved as aminocaproic acid by LUITPOLD on December 1st, 1987.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AMINOCAPROIC?
  • What are the global sales for AMINOCAPROIC?
  • What is Average Wholesale Price for AMINOCAPROIC?
Drug patent expirations by year for AMINOCAPROIC
Drug Prices for AMINOCAPROIC

See drug prices for AMINOCAPROIC

Recent Clinical Trials for AMINOCAPROIC

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Minia UniversityPhase 3
NYU Langone HealthN/A
Assiut UniversityPhase 4

See all AMINOCAPROIC clinical trials

US Patents and Regulatory Information for AMINOCAPROIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira AMINOCAPROIC ACID IN PLASTIC CONTAINER aminocaproic acid INJECTABLE;INJECTION 070010-001 Mar 9, 1987 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma AMINOCAPROIC aminocaproic acid TABLET;ORAL 075602-001 May 24, 2001 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ani Pharms AMINOCAPROIC ACID aminocaproic acid TABLET;ORAL 211629-001 Dec 14, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Optimus AMINOCAPROIC ACID aminocaproic acid TABLET;ORAL 213944-002 Sep 14, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.